ArticleBMC psychiatry2025
Mood states recognition based on Mandarin speech and deep learning in patients with bipolar disorder.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrent assessments of bipolar disorder mainly rely on clinician’s experience and patients’ self-reporting, which has the risk of observer bias and subjective cognitive bias. There is an urgent need for more objective indicators to improve the accuracy of recognizing and monitoring mood states in patients with bipolar disorder. Speech might be a promising marker for recognizing different mood states of bipolar disorder, because of its accessible, objective, and non-invasive features. This study aims to construct a deep learning model based on Mandarin speech to recognize depressive episode, (hypo)manic episode, and euthymic state in bipolar disorder.
methodsFifty-three patients with bipolar disorder were recruited from the outpatient clinic in Tianjin Anding Hospital from March 2023 to April 2024. Speech recordings were collected in a controlled acoustic environment and were pre-processed. Three speech features including the Mel spectrogram, HuBERT and WavLM self-supervised feature were extracted. The speech feature with the highest recognition rate was selected as the basic speech feature for the mood states recognition. Three mood states recognition models were constructed based on deep learning algorithms: (1) the LSTM model, (2) the ECAPA-TDNN model, and (3) our proposed model (Ours). The Ours model enhances the ECAPA-TDNN architecture by integrating an LSTM layer to capture contextual information, followed by processing through a TFA mechanism. The recognition performance of the constructed models is evaluated by WA, UA, and Macro_F1 value.
results19 patients with bipolar disorder were in a (hypo)manic episode, 15 in a depressive episode, and 19 in a euthymic state. The WavLM self-supervised feature had the highest speech recognition rate (90.13%), followed by the HuBERT self-supervised feature (67.56%) and the Mel Spectrum feature (58.09%). The Ours model achieved the best overall performance, with UA, WA, and Macro_F1 of 85.94%, 85.79%, and 85.78%, respectively, which is 6–8% higher than those of LSTM and ECAPA-TDNN.
conclusionsThis study validates the effectiveness of the fusion model of self-supervised features and deep learning in Mandarin speech recognition of bipolar disorder patients’ mood states. The findings provide evidence for the use of speech features as biomarkers to accurately distinguish mood states in bipolar disorder. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.